✦ LIBER ✦

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin

✍ Scribed by Maria Buti; Claudia Mendez; Melanie Schaper; Silvia Sauleda; Auristela Valdes; Francisco Rodriguez-Frias; Rosendo Jardi; Rafael Esteban

Book ID: 116650217
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 332 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2003.11.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

466 HCV core Ag as a predictor of non-re

466 HCV core Ag as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alfa-2B plus ribavirin

✍ M. Buti; A. Valdes; C. Mendez; M. Schaper; S. Sauleda; F. Rodriguez-Frias; R. Ja 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Early hepatitis C virus changes and sust

Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α-2b and ribavirin

✍ J. F. Gallegos-Orozco; A. Loaeza-del Castillo; A. P. Fuentes; M. García-Sandoval 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Chronic hepatitis C genotype 1 patients

Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin

✍ Stephen A. Harrison; Fayez M. Hamzeh; Jian Han; Prashant K. Pandya; Muhammed Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Randomized trial of peginterferon α-2a p

Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients

✍ Shiho Miyase, Katsuki Haraoka, Yoshihiro Ouchida, Yuko Morishita, Shigetoshi Fuj 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 227 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v

Peginterferon alfa-2b plus ribavirin for

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

✍ Savino Bruno; Calogero Cammà; Vito Di Marco; Mariagrazia Rumi; Maria Vinci; Mari 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 373 KB